GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Global Income Fund Inc (AMEX:FCO) » Definitions » ROE %

abrdn Globalome Fund (abrdn Globalome Fund) ROE % : 0.19% (As of Oct. 2023)


View and export this data going back to 2000. Start your Free Trial

What is abrdn Globalome Fund ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. abrdn Globalome Fund's annualized net income for the quarter that ended in Oct. 2023 was $0.10 Mil. abrdn Globalome Fund's average Total Stockholders Equity over the quarter that ended in Oct. 2023 was $51.38 Mil. Therefore, abrdn Globalome Fund's annualized ROE % for the quarter that ended in Oct. 2023 was 0.19%.

The historical rank and industry rank for abrdn Globalome Fund's ROE % or its related term are showing as below:

FCO' s ROE % Range Over the Past 10 Years
Min: -32.01   Med: 4.14   Max: 10.65
Current: 10.23

During the past 13 years, abrdn Globalome Fund's highest ROE % was 10.65%. The lowest was -32.01%. And the median was 4.14%.

FCO's ROE % is ranked better than
70.6% of 1697 companies
in the Asset Management industry
Industry Median: 4.06 vs FCO: 10.23

abrdn Globalome Fund ROE % Historical Data

The historical data trend for abrdn Globalome Fund's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Globalome Fund ROE % Chart

abrdn Globalome Fund Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.65 -6.21 8.52 -32.01 10.65

abrdn Globalome Fund Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 -37.52 -27.61 20.54 0.19

Competitive Comparison of abrdn Globalome Fund's ROE %

For the Asset Management subindustry, abrdn Globalome Fund's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Globalome Fund's ROE % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Globalome Fund's ROE % distribution charts can be found below:

* The bar in red indicates where abrdn Globalome Fund's ROE % falls into.



abrdn Globalome Fund ROE % Calculation

abrdn Globalome Fund's annualized ROE % for the fiscal year that ended in Oct. 2023 is calculated as

ROE %=Net Income (A: Oct. 2023 )/( (Total Stockholders Equity (A: Oct. 2022 )+Total Stockholders Equity (A: Oct. 2023 ))/ count )
=5/( (43.778+50.128)/ 2 )
=5/46.953
=10.65 %

abrdn Globalome Fund's annualized ROE % for the quarter that ended in Oct. 2023 is calculated as

ROE %=Net Income (Q: Oct. 2023 )/( (Total Stockholders Equity (Q: Apr. 2023 )+Total Stockholders Equity (Q: Oct. 2023 ))/ count )
=0.098/( (52.64+50.128)/ 2 )
=0.098/51.384
=0.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Oct. 2023) net income data. ROE % is displayed in the 30-year financial page.


abrdn Globalome Fund  (AMEX:FCO) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Oct. 2023 )
=Net Income/Total Stockholders Equity
=0.098/51.384
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.098 / 1.01)*(1.01 / 70.949)*(70.949 / 51.384)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.7 %*0.0142*1.3808
=ROA %*Equity Multiplier
=0.14 %*1.3808
=0.19 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Oct. 2023 )
=Net Income/Total Stockholders Equity
=0.098/51.384
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0.098 / 0.098) * (0.098 / 1.01) * (1.01 / 70.949) * (70.949 / 51.384)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * 9.7 % * 0.0142 * 1.3808
=0.19 %

Note: The net income data used here is two times the semi-annual (Oct. 2023) net income data. The Revenue data used here is two times the semi-annual (Oct. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


abrdn Globalome Fund ROE % Related Terms

Thank you for viewing the detailed overview of abrdn Globalome Fund's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


abrdn Globalome Fund (abrdn Globalome Fund) Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets, and Sub-Investment Grade Developing Markets.
Executives
Peter Branner other: Director of Sub-Adviser C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
Xavier Meyer other: Director of Sub-Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Katie Lynn Gebauer officer: Vice President C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Katherine A. Corey officer: Vice President 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Ai Hua Aik other: Director of Investment Manager 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Moritz A Sell director C/O USBANCORP FUND SERVICES, 777 E WISCONSIN AVE., MILWAUKEE WI 53202
Grant Thomas Hotson other: Director of Sub-Adviser 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Heather Hasson officer: Vice President C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Brian Kordeck officer: Vice President C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILDADELPHIA PA 19103
Michael Marsico officer: Vice President C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILDADELPHIA PA 19103
Robert W. Hepp officer: Vice President C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILDADELPHIA PA 19103
Andrew Wonil Kim officer: Vice President C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILDADELPHIA PA 19103
Radhika Ajmera director 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Neil Andrew Slater other: Director of Sub-Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022